EDGAR Filing Documents for 0001144204-15-039370

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001144204-15-039370

Filing Date

2015-06-26

Accepted

2015-06-26 16:16:04

Documents

Effectiveness Date

2015-06-26

Document Format Files

Seq	Description	Document	Type	Size
1	DEFINITIVE ADDITIONAL MATERIALS	v414205_defa14a.htm	DEFA14A	20548
	Complete submission text file	0001144204-15-039370.txt		21654

Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036

Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804

Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: DEFA14A | Act: 34 | File No.: 001-36288 | Film No.: 15955305
SIC: 2834 Pharmaceutical Preparations